Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fotheringham SA"'
Autor:
Ryan KA; UK Health Security Agency, Salisbury, United Kingdom., Bewley KR; UK Health Security Agency, Salisbury, United Kingdom., Watson RJ; UK Health Security Agency, Salisbury, United Kingdom., Burton C; UK Health Security Agency, Salisbury, United Kingdom., Carnell O; UK Health Security Agency, Salisbury, United Kingdom., Cavell BE; UK Health Security Agency, Salisbury, United Kingdom., Challis A; UK Health Security Agency, Salisbury, United Kingdom., Coombes NS; UK Health Security Agency, Salisbury, United Kingdom., Davies ER; UK Health Security Agency, Salisbury, United Kingdom., Edun-Huges J; UK Health Security Agency, Salisbury, United Kingdom., Emery K; UK Health Security Agency, Salisbury, United Kingdom., Fell R; UK Health Security Agency, Salisbury, United Kingdom., Fotheringham SA; UK Health Security Agency, Salisbury, United Kingdom., Gooch KE; UK Health Security Agency, Salisbury, United Kingdom., Gowan K; UK Health Security Agency, Salisbury, United Kingdom., Handley A; UK Health Security Agency, Salisbury, United Kingdom., Harris DJ; UK Health Security Agency, Salisbury, United Kingdom., Hesp R; UK Health Security Agency, Salisbury, United Kingdom., Hunter L; UK Health Security Agency, Salisbury, United Kingdom., Humphreys R; UK Health Security Agency, Salisbury, United Kingdom., Johnson R; UK Health Security Agency, Salisbury, United Kingdom., Kennard C; UK Health Security Agency, Salisbury, United Kingdom., Knott D; UK Health Security Agency, Salisbury, United Kingdom., Lister S; UK Health Security Agency, Salisbury, United Kingdom., Morley D; UK Health Security Agency, Salisbury, United Kingdom., Ngabo D; UK Health Security Agency, Salisbury, United Kingdom., Osman KL; UK Health Security Agency, Salisbury, United Kingdom., Paterson J; UK Health Security Agency, Salisbury, United Kingdom., Penn EJ; UK Health Security Agency, Salisbury, United Kingdom., Pullan ST; UK Health Security Agency, Salisbury, United Kingdom., Richards KS; UK Health Security Agency, Salisbury, United Kingdom., Summers S; UK Health Security Agency, Salisbury, United Kingdom., Thomas SR; UK Health Security Agency, Salisbury, United Kingdom., Weldon T; UK Health Security Agency, Salisbury, United Kingdom., Wiblin NR; UK Health Security Agency, Salisbury, United Kingdom., Rayner EL; UK Health Security Agency, Salisbury, United Kingdom., Vipond RT; UK Health Security Agency, Salisbury, United Kingdom., Hallis B; UK Health Security Agency, Salisbury, United Kingdom., Salguero FJ; UK Health Security Agency, Salisbury, United Kingdom., Funnell SGP; UK Health Security Agency, Salisbury, United Kingdom., Hall Y; UK Health Security Agency, Salisbury, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2023 Apr 04; Vol. 19 (4), pp. e1011293. Date of Electronic Publication: 2023 Apr 04 (Print Publication: 2023).
Autor:
Handley A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ryan KA; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Davies ER; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Bewley KR; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Carnell OT; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Challis A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Coombes NS; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Fotheringham SA; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Gooch KE; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Charlton M; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Harris DJ; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Kennard C; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ngabo D; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Weldon TM; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Salguero FJ; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Funnell SGP; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK.; Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.; World Health Organization, Appia 20, 1211 Geneva, Switzerland., Hall Y; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK.
Publikováno v:
Viruses [Viruses] 2023 Mar 14; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 14.
Autor:
Ryan KA; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Schewe KE; Flu-BPD, BioPharmaceutical Development, R&D, AstraZeneca, Liverpool, United Kingdom., Crowe J; Flu-BPD, BioPharmaceutical Development, R&D, AstraZeneca, Liverpool, United Kingdom., Fotheringham SA; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Hall Y; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Humphreys R; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Marriott AC; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Paterson J; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Rayner E; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Salguero FJ; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Watson RJ; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Whittaker CJ; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom., Carroll MW; UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom.; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Dibben O; Flu-BPD, BioPharmaceutical Development, R&D, AstraZeneca, Liverpool, United Kingdom.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Feb 01; Vol. 225 (3), pp. 404-412.
Autor:
Watson RJ; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Tree J; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Fotheringham SA; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Hall Y; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Dong X; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpoolgrid.10025.36, Liverpool, United Kingdom., Steeds K; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Gouriet J; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Salguero FJ; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Burton C; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Pitman J; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Easterbrook L; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Richards KS; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Burton J; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Bewley K; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Bruce C; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Hiscox JA; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpoolgrid.10025.36, Liverpool, United Kingdom.; A*STAR Infectious Diseases Laboratories (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore., Carroll MW; UK Health Security Agency, Porton Down, Salisbury, United Kingdom.; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Funnell SGP; UK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Publikováno v:
Journal of virology [J Virol] 2021 Nov 23; Vol. 95 (24), pp. e0083321. Date of Electronic Publication: 2021 Sep 29.
Autor:
Gooch KE; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Smith TRF; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Salguero FJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Fotheringham SA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Watson RJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Dennis MJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Handley A; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Humphries HE; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Longet S; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Tipton T; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Sarfas C; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Sibley L; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Slack GS; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Rayner E; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Ryan KA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Schultheis K; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Ramos SJ; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., White A; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Charlton S; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Sharpe SA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Gleeson F; Department of Oncology, Oxford University, Oxford, UK., Humeau LM; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Hall Y; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom., Broderick KE; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Carroll MW; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom; Wellcome Centre for Human Genetics, Nuffield Dept of Medicine, Oxford University, OX3 7BN, UK.
Publikováno v:
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4885-4894. Date of Electronic Publication: 2021 Jun 23.
Autor:
Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Spencer AJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thomas KM; National Infection Service, Public Health England, Salisbury, UK., Gooch KE; National Infection Service, Public Health England, Salisbury, UK., Thomas S; National Infection Service, Public Health England, Salisbury, UK., White AD; National Infection Service, Public Health England, Salisbury, UK., Humphries HE; National Infection Service, Public Health England, Salisbury, UK., Wright D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thakur N; The Pirbright Institute, Woking, Surrey, UK., Conceicao C; The Pirbright Institute, Woking, Surrey, UK., Watson R; National Infection Service, Public Health England, Salisbury, UK., Alden L; National Infection Service, Public Health England, Salisbury, UK., Allen L; National Infection Service, Public Health England, Salisbury, UK., Aram M; National Infection Service, Public Health England, Salisbury, UK., Bewley KR; National Infection Service, Public Health England, Salisbury, UK., Brunt E; National Infection Service, Public Health England, Salisbury, UK., Brown P; National Infection Service, Public Health England, Salisbury, UK., Cavell BE; National Infection Service, Public Health England, Salisbury, UK., Cobb R; National Infection Service, Public Health England, Salisbury, UK., Fotheringham SA; National Infection Service, Public Health England, Salisbury, UK., Gilbride C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harris DJ; National Infection Service, Public Health England, Salisbury, UK., Ho CMK; National Infection Service, Public Health England, Salisbury, UK., Hunter L; National Infection Service, Public Health England, Salisbury, UK., Kennard CL; National Infection Service, Public Health England, Salisbury, UK., Leung S; National Infection Service, Public Health England, Salisbury, UK., Lucas V; National Infection Service, Public Health England, Salisbury, UK., Ngabo D; National Infection Service, Public Health England, Salisbury, UK., Ryan KA; National Infection Service, Public Health England, Salisbury, UK., Sharpe H; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sarfas C; National Infection Service, Public Health England, Salisbury, UK., Sibley L; National Infection Service, Public Health England, Salisbury, UK., Slack GS; National Infection Service, Public Health England, Salisbury, UK., Ulaszewska M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Wand N; National Infection Service, Public Health England, Salisbury, UK., Wiblin NR; National Infection Service, Public Health England, Salisbury, UK., Gleeson FV; Department of Oncology, University of Oxford, Oxford, UK., Bailey D; The Pirbright Institute, Woking, Surrey, UK., Sharpe S; National Infection Service, Public Health England, Salisbury, UK., Charlton S; National Infection Service, Public Health England, Salisbury, UK., Salguero FJ; National Infection Service, Public Health England, Salisbury, UK., Carroll MW; National Infection Service, Public Health England, Salisbury, UK.; Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. sarah.gilbert@ndm.ox.ac.uk.
Publikováno v:
Communications biology [Commun Biol] 2021 Jul 26; Vol. 4 (1), pp. 915. Date of Electronic Publication: 2021 Jul 26.
Autor:
Salguero FJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., White AD; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Slack GS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Fotheringham SA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Bewley KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gooch KE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Longet S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Humphries HE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Watson RJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hunter L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Ryan KA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hall Y; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Sibley L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Sarfas C; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Allen L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Aram M; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Brunt E; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Brown P; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Buttigieg KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Cavell BE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Cobb R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Coombes NS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Darby A; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Daykin-Pont O; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Elmore MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Garcia-Dorival I; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Gkolfinos K; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Godwin KJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gouriet J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Halkerston R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Harris DJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hender T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Ho CMK; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Kennard CL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Knott D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Leung S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Lucas V; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Mabbutt A; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Morrison AL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Nelson C; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Ngabo D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Paterson J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Penn EJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Pullan S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Taylor I; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Tipton T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Thomas S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Tree JA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Turner C; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Vamos E; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Wand N; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Wiblin NR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Charlton S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Dong X; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Hallis B; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Pearson G; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Rayner EL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Nicholson AG; Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial College, London, UK., Funnell SG; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hiscox JA; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Infectious Diseases Horizontal Technology Centre (ID HTC), A*STAR, Singapore, Singapore., Dennis MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gleeson FV; Department of Oncology, Oxford University, Oxford, UK., Sharpe S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Carroll MW; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK. miles.carroll@phe.gov.uk.; Nuffield Department of Medicine, Wellcome Trust Centre for Human Genetics, Oxford University, Oxford, OX3 7BN, UK. miles.carroll@phe.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Feb 24; Vol. 12 (1), pp. 1260. Date of Electronic Publication: 2021 Feb 24.
Autor:
Ryan KA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Bewley KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Fotheringham SA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Slack GS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Brown P; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Hall Y; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Wand NI; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Marriott AC; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Cavell BE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Tree JA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Allen L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Aram MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Bean TJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Brunt E; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Buttigieg KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Carter DP; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Cobb R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Coombes NS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Findlay-Wilson SJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Godwin KJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Gooch KE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Gouriet J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Halkerston R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Harris DJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Hender TH; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Humphries HE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Hunter L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Ho CMK; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Kennard CL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Leung S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Longet S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Ngabo D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Osman KL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Paterson J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Penn EJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Pullan ST; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Rayner E; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Skinner O; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Steeds K; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Taylor I; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Tipton T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Thomas S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Turner C; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Watson RJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Wiblin NR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Charlton S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Hallis B; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Hiscox JA; Institute of Infection and Global Health, University of Liverpool, Liverpool, L69 2BE, UK., Funnell S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Dennis MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Whittaker CJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Catton MG; Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Druce J; Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Salguero FJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK., Carroll MW; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. miles.carroll@phe.gov.uk.; Nuffield Department of Medicine, Oxford University, Oxford, OX1 3SY, UK. miles.carroll@phe.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Jan 04; Vol. 12 (1), pp. 81. Date of Electronic Publication: 2021 Jan 04.
Autor:
Proud PC; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Tsitoura D; Ena Respiratory, Level 9, 31 Queen St, Melbourne, Victoria, 3000, Australia., Watson RJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Chua BY; Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia., Aram MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Bewley KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Cavell BE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Cobb R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Dowall S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Fotheringham SA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Ho CMK; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Lucas V; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Ngabo D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Rayner E; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Ryan KA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Slack GS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Thomas S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Wand NI; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Yeates P; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG., Demaison C; Ena Respiratory, Level 9, 31 Queen St, Melbourne, Victoria, 3000, Australia., Zeng W; Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia., Holmes I; Ena Respiratory, Level 9, 31 Queen St, Melbourne, Victoria, 3000, Australia., Jackson DC; Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia., Bartlett NW; Viral Immunology and Respiratory Disease group and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Mercuri F; Ena Respiratory, Level 9, 31 Queen St, Melbourne, Victoria, 3000, Australia. Electronic address: fm@enarespiratory.com., Carroll MW; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, United Kingdom SP4 0JG; Nuffield Dept of Medicine, Oxford University, Oxford, UK. Electronic address: miles.carroll@phe.gov.uk.
Publikováno v:
EBioMedicine [EBioMedicine] 2021 Jan; Vol. 63, pp. 103153. Date of Electronic Publication: 2020 Dec 03.
Autor:
Mazhab-Jafari MT; Department of Chemistry, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada., Das R, Fotheringham SA, SilDas S, Chowdhury S, Melacini G
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2007 Nov 21; Vol. 129 (46), pp. 14482-92. Date of Electronic Publication: 2007 Oct 31.